Cited 12 times in
Presence of a survival benefit of HLA-incompatible living donor kidney transplantation compared to waiting or HLA-compatible deceased donor kidney transplantation with a long waiting time
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 김명수 | - |
dc.contributor.author | 김순일 | - |
dc.contributor.author | 김유선 | - |
dc.contributor.author | 이주한 | - |
dc.date.accessioned | 2021-09-29T01:33:22Z | - |
dc.date.available | 2021-09-29T01:33:22Z | - |
dc.date.issued | 2021-07 | - |
dc.identifier.issn | 0085-2538 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/184426 | - |
dc.description.abstract | HLA-incompatible living donor kidney transplantation (LDKT) is one of efforts to increase kidney transplantation opportunity for sensitized patients with kidney failure. However, there are conflicting reports for outcomes of HLA-incompatible kidney transplantation compared to patients who wait for HLA-compatible deceased donor kidney transplantation (DDKT) in the United States and United Kingdom. Waiting for an HLA-compatible DDKT is relatively disadvantageous in Korea, because the average waiting time is more than five years. To study this further, we compared outcomes of HLA-incompatible LDKT with those who wait for HLA-compatible DDKT in Korea. One hundred eighty nine patients underwent HLA-incompatible LDKT after desensitization between 2006 and 2018 in two Korean hospitals (42 with a positive complement-dependent cytotoxicity cross-match, 89 with a positive flow cytometric cross-match, and 58 with a positive donor-specific antibody with negative cross-match). The distribution of matched variables was comparable between the HLA-incompatible LDKT group and the matched control groups (waiting-list-only group; and the waiting-list-or-HLA-compatible-DDKT groups; 930 patients each). The HLA-incompatible LDKT group showed a significantly better patient survival rate compared to the waiting-list-only group and the waiting-list-or-HLA-compatible-DDKT groups. Furthermore, the HLA-incompatible LDKT group showed a significant survival benefit as compared with the matched groups at all strength of donor-specific antibodies. Thus, HLA-incompatible LDKT could have a survival benefit as compared with patients who were waitlisted for HLA-compatible DDKT or received HLA-compatible DDKT in Korea. This suggests that HLA-incompatible LDKT as a good option for sensitized patients with kidney failure in countries with prolonged waiting times for DDKT. | - |
dc.description.statementOfResponsibility | restriction | - |
dc.language | English | - |
dc.publisher | Elsevier | - |
dc.relation.isPartOf | KIDNEY INTERNATIONAL | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.subject.MESH | Graft Survival | - |
dc.subject.MESH | Humans | - |
dc.subject.MESH | Kidney Transplantation* / adverse effects | - |
dc.subject.MESH | Living Donors | - |
dc.subject.MESH | Republic of Korea | - |
dc.subject.MESH | United Kingdom | - |
dc.subject.MESH | United States | - |
dc.subject.MESH | Waiting Lists* | - |
dc.title | Presence of a survival benefit of HLA-incompatible living donor kidney transplantation compared to waiting or HLA-compatible deceased donor kidney transplantation with a long waiting time | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Surgery (외과학교실) | - |
dc.contributor.googleauthor | Tai Yeon Koo | - |
dc.contributor.googleauthor | Ju Han Lee | - |
dc.contributor.googleauthor | Sang-Il Min | - |
dc.contributor.googleauthor | Yonggu Lee | - |
dc.contributor.googleauthor | Myung Soo Kim | - |
dc.contributor.googleauthor | Jongwon Ha | - |
dc.contributor.googleauthor | Soon Il Kim | - |
dc.contributor.googleauthor | Curie Ahn | - |
dc.contributor.googleauthor | Yu Seun Kim | - |
dc.contributor.googleauthor | Jayoun Kim | - |
dc.contributor.googleauthor | Kyu Ha Huh | - |
dc.contributor.googleauthor | Jaeseok Yang | - |
dc.identifier.doi | 10.1016/j.kint.2021.01.027 | - |
dc.contributor.localId | A00424 | - |
dc.contributor.localId | A00649 | - |
dc.contributor.localId | A00785 | - |
dc.contributor.localId | A03163 | - |
dc.contributor.localId | A04344 | - |
dc.relation.journalcode | J01941 | - |
dc.identifier.eissn | 1523-1755 | - |
dc.identifier.pmid | 33647326 | - |
dc.identifier.url | https://www.sciencedirect.com/science/article/pii/S0085253821002581 | - |
dc.subject.keyword | HLA incompatible | - |
dc.subject.keyword | desensitization | - |
dc.subject.keyword | donor-specific antibody | - |
dc.subject.keyword | kidney transplantation | - |
dc.subject.keyword | waiting time | - |
dc.contributor.alternativeName | Kim, Myoung Soo | - |
dc.contributor.affiliatedAuthor | 김명수 | - |
dc.contributor.affiliatedAuthor | 김순일 | - |
dc.contributor.affiliatedAuthor | 김유선 | - |
dc.contributor.affiliatedAuthor | 이주한 | - |
dc.citation.volume | 100 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 206 | - |
dc.citation.endPage | 214 | - |
dc.identifier.bibliographicCitation | KIDNEY INTERNATIONAL, Vol.100(1) : 206-214, 2021-07 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.